Patients 0 8 0 8 O
must 9 13 9 13 O
be 14 16 14 16 O
ambulatory 17 27 17 27 O
with 28 32 28 32 O
good 33 37 33 37 O
performance 38 49 38 49 O
status 50 56 50 56 O
( 57 58 57 58 O
ECOG 58 62 58 62 B-clinical_variable
0 63 64 63 64 B-lower_bound
or 65 67 65 67 O
1 68 69 68 69 B-upper_bound
) 69 70 69 70 O

Patients 0 8 71 79 O
must 9 13 80 84 O
be 14 16 85 87 O
eligible 17 25 88 96 O
to 26 28 97 99 O
receive 29 36 100 107 O
nivolumab 37 46 108 117 B-treatment
in 47 49 118 120 I-treatment
combination 50 61 121 132 I-treatment
with 62 66 133 137 I-treatment
ipilimumab 67 77 138 148 I-treatment
treatment 78 87 149 158 I-treatment
per 88 91 159 162 O
institutional 92 105 163 176 O
guidelines 106 116 177 187 O

Patients 0 8 188 196 O
must 9 13 197 201 O
have 14 18 202 206 O
a 19 20 207 208 O
tissue 21 27 209 215 O
block 28 33 216 221 O
( 34 35 222 223 O
or 35 37 223 225 O
20 38 40 226 228 O
unstained 41 50 229 238 O
slides 51 57 239 245 O
) 57 58 245 246 O
available 59 68 247 256 O
with 69 73 257 261 O
adequate 74 82 262 270 O
tumor 83 88 271 276 B-cancer
to 89 91 277 279 O
perform 92 99 280 287 O
multiplex 100 109 288 297 B-treatment
immunohistochemistry 110 130 298 318 I-treatment
and 131 134 319 322 O
nucleic 135 142 323 330 B-treatment
acids 143 148 331 336 I-treatment
analyses 149 157 337 345 I-treatment
( 158 159 346 347 O
i.e. 160 164 348 352 O
whole 165 170 353 358 O
exome 171 176 359 364 O
sequencing 177 187 365 375 O
) 187 188 375 376 O

Patients 0 8 377 385 O
who 9 12 386 389 O
have 13 17 390 394 O
received 18 26 395 403 O
prior 27 32 404 409 B-treatment
immunotherapy 33 46 410 423 I-treatment
for 47 50 424 427 O
unresectable 51 63 428 440 O
or 64 66 441 443 O
metastatic 67 77 444 454 B-cancer
disease 78 85 455 462 I-cancer

Patients 0 8 463 471 O
with 9 13 472 476 O
a 14 15 477 478 O
history 16 23 479 486 O
of 24 26 487 489 O
brain 27 32 490 495 B-cancer
metastases 33 43 496 506 I-cancer
must 44 48 507 511 O
have 49 53 512 516 O
completed 54 63 517 526 O
treatment 64 73 527 536 O
( 74 75 537 538 O
i.e. 75 79 538 542 O
surgery 80 87 543 550 B-treatment
or 88 90 551 553 O
radiation 91 100 554 563 B-treatment
) 100 101 563 564 O
1 102 103 565 566 B-upper_bound
month 104 109 567 572 I-upper_bound
prior 110 115 573 578 I-upper_bound
to 116 118 579 581 O
enrollment 119 129 582 592 O
and 130 133 593 596 O
have 134 138 597 601 O
no 139 141 602 604 O
evidence 142 150 605 613 O
of 151 153 614 616 O
disease 154 161 617 624 O
or 162 164 625 627 O
edema 165 170 628 633 O
on 171 173 634 636 O
brain 174 179 637 642 B-treatment
CT 180 182 643 645 I-treatment
or 183 185 646 648 O
head 186 190 649 653 B-treatment
MRI 191 194 654 657 I-treatment

Patients 0 8 658 666 O
with 9 13 667 671 O
untreated 14 23 672 681 O
brain 24 29 682 687 B-cancer
metastases 30 40 688 698 I-cancer
, 40 41 698 699 O
leptomeningeal 42 56 700 714 B-cancer
disease 57 64 715 722 I-cancer
, 64 65 722 723 O
or 66 68 724 726 O
seizure 69 76 727 734 B-chronic_disease
disorders 77 86 735 744 I-chronic_disease

